Eric Benson
Eric Benson

MANAGEMENT & STRATEGY
Adjunct Lecturer of Health Enterprise Management

Print Overview

Eric Benson is a Lecturer of Kellogg Innovation & Entrepreneurship Initiative and has over 15 years of business strategy, product planning, licensing and M&A, and finance experience in the Healthcare Product industry. He conducted new product forecasting and brand strategy at Astellas Pharma, and continues to work with emerging healthcare product companies in building their go-to-market strategy and operations to achieve funding, joint venture partnerships and product launch. He also lecturers at Northwestern’s Masters in Biotechnology Program, where he administers their Technology Commercialization course. In addition to his experience, Eric holds an undergraduate degree in Biomedical Engineering from Vanderbilt University and an MBA in Finance and Entrepreneurship from The University of Chicago.

Eric has experience in valuing and optimizing Infectious Disease, Immunology, Urology, Neuroscience and Cardiovascular therapeutics in both inpatient and outpatient settings.  Additionally, he has worked in the Diagnostics sector on detection devices for cancer, congestive heart failure and Type II diabetes markers.  Finally, he began his healthcare career in bioinformatics, starting off as a researcher and progressing to marketing and business development.

In related matters, Eric is a member of iBIO’s Propel organization, guiding emerging healthcare product companies towards funding and commercial success; and was on the organizational subcommittee to help launch Chicago’s downtown bio hub, MATTER, designed to support and educate healthcare start-ups.

Print Vita
Education
MBA, 2005, Economics and Entrepreneurship, Booth School of Business, University of Chicago
Bachelor of Engineering, 1999, Biomedical Engineering, Vanderbilt University

Academic Positions
MBP’s Lecturing Administrator of Technology Commercialization, Northwestern University, 2013-present

Other Professional Experience
Healthcare Strategic Consulting – Business Development & Product Planning, Lucic Partners, LLC, 2008-present
New Product Analysis – Forecasting, Strategy & Market Intelligence, Astellas Pharma US, Inc., 2012-2013
Senior Analyst – M&A Healthcare Investment Banking, Dresner Partners Investment Bank, 2006-2007
Project Manager – Strategic Consulting, Market Insights, Inc., 2001-2005
Business Development Manager, Integrated Genomics, Inc., 1999-2001

 
Print Research

 
Print Teaching
Full-Time / Part-Time MBA
Medical Product Early Stage Commercialization (KIEI-911-0)

Formerly ENTR-911-0

This new course offers students an experiential learning opportunity to work directly in the commercialization process for innovative, pre-commercial medical product technologies. Students will be placed on four-to-five member teams based on their skills, experience and interests. Each team will function as consultants working with select Northwestern tech transfer companies curated by Northwestern’s INVO (Innovation and New Ventures Office). Each company will present their technology on the first day of class, after which students will select their top three choices and will be matched by the faculty advisers on a first come basis. Once matched, students will work with their respective companies to build a complete company investor deck that will be delivered to a panel of industry and finance experts at the end of the term. The insights from this hands-on course will be most beneficial to students with an interest in entrepreneurship, product design, intellectual property, early stage financing and medical product marketing.

Note: This course may not be dropped after the first week of the quarter.